Levels of interleukin-35 and its relationship with regulatory T-cells in chronic hepatitis B patients

Viral Immunology

Volumn 28, Issue 2, 2015, Pages 93-100

  Shi, Yin Yue ^a,b   Dai, Ming Jia ^a   Wu, Gui Ping ^a   Zhou, Pei Pei ^a   Fang, Yuan ^a   Yan, Xue Bing ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b XUZHOU CHILDREN S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 35; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; HEPATITIS B; HUMAN; HUMAN CELL; LIVER NECROSIS; MAJOR CLINICAL STUDY; NONHUMAN; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BLOOD; CHRONIC HEPATITIS B; IMMUNOLOGY; LIVER; MOUSE; PATHOLOGY;

MURINAE;

ANIMALS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKINS; LIVER; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 84923076268     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2014.0058     Document Type: Article

References (22)

1. Asseman C, Mauze S, Leach MW, et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
2. Allan SE, Song-Zhao GX, Abraham T, et al. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3[J]. Eur J Immunol 2008;38:3282-3289.
3. Belkai DY, and Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6:353-360.
4. Chaturvedi V, Collison LW, Guy CS, et al. Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance. J Immunol 2011;186:1-6.
5. Collison LW, Workman CJ, Kuo TT, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007;450:566-569.
6. Fahlé n L, Read S, Gorelik L, et al. T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells. J Exp Med 2005;201:737-746.
7. Hori S, Nomura T, and Sakaguchi S. Control of regulatory T cells development by the transcription factor Foxp3. Science 2003;299:1057-1061.
8. Liu F, Tong F, He Y, et al. Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin Immunol 2011;139:1-5.
9. Lok AS, and McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-662.
10. Neurath MF. IL-12 family members in experimental colitis. Mucosal Immunol 2008;S28-30.
11. Niedbala W, Wei XQ, Cai B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulation T cells and suppression of Thl7 cells. Eur J Immunol 2007;37:3021-3029.
12. Paust S, Lu L, McCarty N, et al. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 2004;101:10398-10403.
13. Reddy J, Illes Z, Zhang X, et al. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2004;101:15434-15439.
14. Shimizu J, Yamazaki S, Takahashi T, et al. Stimulation of CD25 (+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-142.
15. Siemasko KF, Gao J, Calder VL, et al. In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci 2008;49:5434-5440.
16. Suri-Payer E, and Cantor H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4+CD25+ T cells. J Autoimmun 2001;16:115-123.
17. Takahashi T, Kuniyasu Y, Toda M, et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
18. Tang Q, Adams JY, Tooley AJ, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006;7:83-92.
19. Thornton AM, and Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
20. von Boehmer H. Mechanisms of suppression by suppressor T cells. J Nat Immunol 2005;6:338-344.
21. Yang J, Yang M, Htut TM, et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 2008;8:1204-1214.
22. Zorn E, Nelson EA, Mohseni M, et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 2006;108:1571-1579.